Dr. Weyhenmeyer is the Senior Vice President for Research at the Research Foundation of the State University of New York and Senior Vice Provost for Research and Economic Development for the State University of New York. As such, he serves as the senior research officer for both the Research Foundation of SUNY and the State University of New York System. Dr. Weyhenmeyer was previously the Interim Vice President for Technology and Economic Development at the University of Illinois. In that role, he served as the principal of the member for the University’s limited liability companies, Illinois VENTURES, LLC and the University of Illinois Research Park, LLC, as well as the Director of the Research Park at the University of Illinois. He is an experienced senior administrator having held several executive administrative appointments at Illinois, including Associate Vice President for Academic Affairs and Associate Vice President for Economic Development and Corporate Relations. He was the founding Managing Director of Illinois VENTURES, LLC and Executive Director of the Illinois Technology Enterprise Center, which focus on the early-stage development of technology-based companies deriving from research institutions and universities. Dr. Weyhenmeyer served on the Illinois Fund-to-Fund Review Board, investing in venture capital firms with an early-stage focus. He also has served as the chief scientific officer for a medical device company and chief operating officer for a drug discovery / drug delivery company.
Dr. Weyhenmeyer is an Adjunct Professor of Cell Biology, Pathology and Neuroscience at the University of Illinois Urbana/Champaign. He holds a B.A. from Knox College and a Ph.D. from Indiana University, and was a postdoctoral fellow in the Departments of Medicine and Physiology/Biophysics at the University of Iowa. Trained as a cell biologist / neuroscientist, Dr. Weyhenmeyer has conducted basic and applied research on degenerative brain disorders with a focus on stroke. He has been funded by the National Institutes of Health, the National Science Foundation, March of Dimes, American Heart Association, the PHARMA Foundation and private industry. He has authored more than 200 publications and serves on a number of national scientific committees. He has served on numerous boards, including Argonne National Laboratory Board of Governors, Fermi Laboratory Board of Directors, and the American Heart Association Board of Directors, as well as scientific advisory boards for companies in gene technology and drug development sectors. Dr. Weyhenmeyer was recently elected to membership in the Royal Swedish Academy for Engineering Sciences.